Blood proteins shift during Alzheimer's treatment and may help monitor the effects of the medication

Patients with early symptoms of Alzheimer's disease may be prescribed anti-amyloid therapy, which can help clear the sticky clumps of amyloid protein in the brain that characterize Alzheimer's. While these treatments cannot cure Alzheimer's or restore cognitive function to normal, they have been shown to slow the progression of the disease. Their effects may vary, and clinicians have had no way to monitor treatment in an individual patient besides expensive brain scans.

Read it at Medical Xpress ↗

← Front page